Article(id=1329914722293494181, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329914644128444824, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2024.07.017, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1708272000000, receivedDateStr=2024-02-19, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795005978414, onlineDateStr=2026-11-18, pubDate=1720540800000, pubDateStr=2024-07-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795005978414, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795005978414, creator=13701087609, updateTime=1795005978414, updator=13701087609, issue=Issue{id=1329914644128444824, tenantId=1146029695717560320, journalId=1319690259887390882, year='2024', volume='55', issue='7', pageStart='887', pageEnd='1044', issueExtLink='null', onlineDate='null', pubDate='1720540800000', pubDateStr='2024-07-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795005959779, creator='13701087609', updateTime=1795136174555, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330460804954043169, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329914644128444824, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330460804954043170, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329914644128444824, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1024, endPage=1031, ext={EN=ArticleExt(id=1329914722486432166, articleId=1329914722293494181, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Regulatory Policies, Challenges and Development Trends of Excipients in Pediatric Formulations, columnId=1322624444787438528, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Pharmaceutical Management & Information, runingTitle=null, highlight=null, articleAbstract=null, authors=Qiwei WANG1, 2, Guiliang CHEN3, *, authorsList=Qiwei WANG, Guiliang CHEN, authorCompany=null, correspAuthors=Guiliang CHEN, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329914723107189159, articleId=1329914722293494181, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=儿童制剂用辅料的监管政策、挑战与发展趋势, columnId=1322624444934239170, journalTitle=中国医药工业杂志, columnName=药学管理与信息, runingTitle=null, highlight=null, articleAbstract=

儿童是药物治疗的特殊群体,儿童与成人的生理特性和药物代谢特点存在差异。随着对儿童用药可及性的重视程度不断加深,越来越多的儿童适宜制剂亟待开发;而儿童对制剂用辅料的安全性和适宜性有着特殊要求。文章综述了全球主要国家和地区关于儿童制剂用辅料的监管政策和使用现状。尽管各国对儿童制剂用辅料出台了一些监管政策,但仍存在儿童频繁暴露于不安全辅料、药品说明书中辅料信息缺乏、儿童制剂可用辅料信息少等问题。对此,文章提出完善安全性评估体系、建立信息共享机制和加大创新辅料和创新技术研发的思路,以期促进儿童制剂用辅料的发展,为增进儿童的健康和福祉作出贡献。

, authors=王奇巍1, 2, 陈桂良3, *, authorsList=王奇巍, 陈桂良, authorCompany=null, correspAuthors=陈桂良, authorNote=

王奇巍(1984—),博士研究生,副研究员,专业方向:医药政策、医药信息研究。

, correspAuthorsNote=
陈桂良(1964—),男,研究员,博士生导师,从事药品监管科学的研究。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=u49yLtqXiYDmc0tDapqxJw==, magXml=enlho+InfEQNmdakg395oA==, pdfUrl=null, pdf=oELplk44Um4M51qgCorcVQ==, pdfFileSize=1818420, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=xO7sGF0wFmFlLH6ZU6lb5A==, mapNumber=null, fund=null)}, authors=[Author(id=1329914723581145522, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914723665031605, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, authorId=1329914723581145522, language=EN, stringName=Qiwei WANG, firstName=Qiwei, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.China State Institute of Pharmaceutical Industry, Shanghai 201203
2.China National Pharmaceutical Industry Information Center, Shanghai 200040, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914723736334774, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, authorId=1329914723581145522, language=CN, stringName=王奇巍, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.中国医药工业研究总院,上海 201203
2.中国医药工业信息中心,上海 200040, bio={"content":"

王奇巍(1984—),博士研究生,副研究员,专业方向:医药政策、医药信息研究。

"}, bioImg=null, bioContent=

王奇巍(1984—),博士研究生,副研究员,专业方向:医药政策、医药信息研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914723283349928, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, xref=1., ext=[AuthorCompanyExt(id=1329914723295932841, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, companyId=1329914723283349928, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1329914723304321450, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, companyId=1329914723283349928, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1329914723388207531, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, xref=2., ext=[AuthorCompanyExt(id=1329914723396596140, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, companyId=1329914723388207531, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.China National Pharmaceutical Industry Information Center, Shanghai 200040), AuthorCompanyExt(id=1329914723409179053, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, companyId=1329914723388207531, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国医药工业信息中心,上海 200040)])]), Author(id=1329914723811832248, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=chenguiliang@smda.sh.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329914723891524026, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, authorId=1329914723811832248, language=EN, stringName=Guiliang CHEN, firstName=Guiliang, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914723979604411, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, authorId=1329914723811832248, language=CN, stringName=陈桂良, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.上海药品审评核查中心,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914723497259438, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, xref=3., ext=[AuthorCompanyExt(id=1329914723505648047, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, companyId=1329914723497259438, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203), AuthorCompanyExt(id=1329914723514036656, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, companyId=1329914723497259438, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.上海药品审评核查中心,上海 201203)])])], keywords=[Keyword(id=1329914724071879100, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, language=CN, orderNo=1, keyword=儿童制剂用辅料), Keyword(id=1329914724130599357, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, language=CN, orderNo=2, keyword=监管政策), Keyword(id=1329914724210291134, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, language=CN, orderNo=3, keyword=发展趋势)], refs=[Reference(id=1329914724315148735, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=BATCHELOR H K, MARRIOTT J F.Paediatric pharmacokinetics: key considerations [J].Br J Clin Pharmacol, 2015, 79(3): 395-404., articleTitle=null, refAbstract=null), Reference(id=1329914724394840512, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=THABET Y, KLINGMANN V, BREITKREUTZ J.Drug formulations: standards and novel strategies for drug administration in pediatrics [J].J Clin Pharmacol, 2018, 58(Suppl 10): S26-S35., articleTitle=null, refAbstract=null), Reference(id=1329914724474532289, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=TAN D C T, KHONG Y M, MOUNT S, et al.Pediatric formulation development - challenges of today and strategies for tomorrow: summary report from M-CERSI workshop 2019[J].Eur J Pharm Biopharm, 2021, 164: 54-65., articleTitle=null, refAbstract=null), Reference(id=1329914724545835458, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=QUIJANO RUIZ B, DESFONTAINE E, ARENAS-LÓPEZ S, et al.Pediatric formulation issues identified in Paediatric Investigation Plans [J].Expert Rev Clin Pharmacol, 2014, 7(1): 25-30., articleTitle=null, refAbstract=null), Reference(id=1329914724612944323, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=FABIANO V, MAMELI C, ZUCCOTTI G V.Paediatric pharmacology: remember the excipients [J].Pharmacol Res, 2011, 63(5): 362-365., articleTitle=null, refAbstract=null), Reference(id=1329914724684247492, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=ROUAZ K, CHICLANA-RODRÍGUEZ B, NARDI-RICART A, et al.Excipients in the paediatric population: a review [J].Pharmaceutics, 2021, 13(3): 387., articleTitle=null, refAbstract=null), Reference(id=1329914724768133573, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Committee for Medicinal Products for Human Use.Reflection paper: formulations of choice for the paediatric population [EB/OL].(2007-07-28) [2023-10-08].https://www.ema.europa.eu/en/documents/scientific-guideline/reflection-paper-formulations-choice-paediatric-population_en.pdf., articleTitle=null, refAbstract=null), Reference(id=1329914724839436742, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA.Excipients in the dossier for application marketing authorisation of a medicinal product - scientific guideline [EB/OL].(2018-09-17)[2023-10-08].https://www.ema.europa.eu/en/excipients-dossier-application-marketing-authorisation-medicinal-product-scientific-guideline., articleTitle=null, refAbstract=null), Reference(id=1329914724906545607, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA.Pharmaceutical development of medicines for paediatric use [EB/OL].(2018-09-17)[2023-10-08].https://www.ema.europa.eu/en/pharmaceutical-development-medicines-paediatric-use-scientific-guideline., articleTitle=null, refAbstract=null), Reference(id=1329914724990431688, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA.Excipients labelling [EB/OL].(2018-09-17)[2023-10-08].https://www.ema.europa.eu/en/human-regulatory/marketing-authorisation/product-information/reference-guidelines/excipients-labelling., articleTitle=null, refAbstract=null), Reference(id=1329914725065929161, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Guidance for industry nonclinical studies for the safety evaluation of pharmaceutical excipients [EB/OL].[2023-10-08].https://www.fda.gov/media/72260/download., articleTitle=null, refAbstract=null), Reference(id=1329914725145620938, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=SAITO J, AGRAWAL A, PATRAVALE V, et al.The current states, challenges, ongoing efforts, and future perspectives of pharmaceutical excipients in pediatric patients in each country and region [J].Children (Basel), 2022, 9(4): 453., articleTitle=null, refAbstract=null), Reference(id=1329914725212729803, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.国家药监局药审中心关于发布《儿童用药(化学药品)药学开发指导原则(试行)》的通告(2020年第67号)[EB/OL].(2020-12-31)[2023-10-13].https://www.cde.org.cn/main/news/viewInfoCommon/95102a5facaf8fd4430d0916a24eab53., articleTitle=null, refAbstract=null), Reference(id=1329914725288227276, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=原国家食品药品监督管理局.药品说明书和标签管理规定[EB/OL].(2006-03-15)[2023-10-13].https://www.samr.gov.cn/zw/zfxxgk/fdzdgknr/bgt/art/2023/art_b1a64fa-4b9314ecabadf3c6662b70c48.html., articleTitle=null, refAbstract=null), Reference(id=1329914725359530445, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.国家药监局药审中心关于发布《化学药品说明书及标签药学相关信息撰写指导原则(试行)》的通告(2023年第20号)[EB/OL].(2023-03-20)[2023-10-13].https://www.cde.org.cn/main/news/viewInfoCommon/defca6a1f3ba33d0bad6f309e-5a0b816., articleTitle=null, refAbstract=null), Reference(id=1329914725435027918, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA.ICH Topic E11: clinical investigation of medicinal products in the paediatric population [EB/OL].[2023-10-08].https://www.ema.europa.eu/en/documents/scientific-guideline/e-11-clinical-investigation-medicinal-products-paediatric-population-step-5_en.pdf., articleTitle=null, refAbstract=null), Reference(id=1329914725510525391, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=ICH.Addendum to ICH E11: clinical investigation of medicinal products in the pediatric population E11(R1) [EB/OL].(2017-08-18)[2023-10-08].https://database.ich.org/sites/default/files/E11_R1_Addendum.pdf., articleTitle=null, refAbstract=null), Reference(id=1329914725573439952, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=WHO.TRS 885 - annex 5: WHO good manufacturing practices for the manufacture of pharmaceutical excipients[EB/OL].(1999-09-30)[2023-11-30].https://www.who.int/publications/m/item/trs885-annex5., articleTitle=null, refAbstract=null), Reference(id=1329914725640548817, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=NELLIS G, METSVAHT T, VARENDI H, et al.Potentially harmful excipients in neonatal medicines: a pan-European observational study [J].Arch Dis Child, 2015, 100(7): 694-699., articleTitle=null, refAbstract=null), Reference(id=1329914725703463378, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=LASS J, NAELAPÄÄ K, SHAH U, et al.Hospitalised neonates in Estonia commonly receive potentially harmful excipients [J].BMC Pediatr, 2012, 12: 136., articleTitle=null, refAbstract=null), Reference(id=1329914725774766547, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=AKINMBONI T O, DAVIS N L, FALCK A J, et al.Excipient exposure in very low birth weight preterm neonates [J].J Perinatol, 2018, 38(2): 169-174., articleTitle=null, refAbstract=null), Reference(id=1329914725846069716, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=许锦,刘彬,王庆阳,等.某三级甲等儿童医院中成药说明书辅料标明情况及风险控制建议[J].中国药师,2018,21(11):2020-2022., articleTitle=null, refAbstract=null), Reference(id=1329914725904789973, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=TURNER M A, DUNCAN J C, SHAH U, et al.Risk assessment of neonatal excipient exposure: lessons from food safety and other areas [J].Adv Drug Deliv Rev, 2014, 73: 89-101., articleTitle=null, refAbstract=null), Reference(id=1329914725967704534, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=BATCHELOR H K, FOTAKI N, KLEIN S.Paediatric oral biopharmaceutics: key considerations and current challenges[J].Adv Drug Deliv Rev, 2014, 73: 102-126., articleTitle=null, refAbstract=null), Reference(id=1329914726030619095, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=STOLTENBERG I, WINZENBURG G, BREITKREUTZ J.Solid oral dosage forms for children - formulations, excipients and acceptance issues [J].J Appl Ther Res, 2010, 7(4): 141-146., articleTitle=null, refAbstract=null), Reference(id=1329914726097727960, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=BREITKREUTZ J, BOOS J.Paediatric and geriatric drug delivery [J].Expert Opin Drug Deliv, 2007, 4(1): 37-45., articleTitle=null, refAbstract=null), Reference(id=1329914726164836825, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=YOCHANA S, YU M, ALVI M, et al.Pharmaceutical excipients and pediatric formulations [J].Chim Oggi, 2012, 30(5): 56-61., articleTitle=null, refAbstract=null), Reference(id=1329914726236139994, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=SHESKEY P J, COOK W G, CABLE C G.Handbook of pharmaceutical excipients [M].8th, London: Pharmaceutical Press, 2017., articleTitle=null, refAbstract=null), Reference(id=1329914726303248859, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=NAKAMA K A, DOS SANTOS R B, SERPA P, et al.Organoleptic excipients used in pediatric antibiotics [J].Arch Pediatr, 2019, 26(7): 431-436., articleTitle=null, refAbstract=null), Reference(id=1329914726378746332, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=MCCANN D, BARRETT A, COOPER A, et al.Food additives and hyperactive behaviour in 3-year-old and 8/9-year-old children in the community: a randomised, double-blinded, placebo-controlled trial [J].Lancet, 2007, 370(9598): 1560-1567., articleTitle=null, refAbstract=null), Reference(id=1329914726445855197, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=SCHAB D W, TRINH N H.Do artificial food colors promote hyperactivity in children with hyperactive syndromes? A meta-analysis of double-blind placebo-controlled trials [J].J Dev Behav Pediatr, 2004, 25(6): 423-434., articleTitle=null, refAbstract=null), Reference(id=1329914726504575454, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=高悦,江军飞.《国家基本医疗保险、工伤保险和生育保险目录(2020版)》儿童专用中成药现状调研[J].儿科药学杂志,2022,28(4):4-7., articleTitle=null, refAbstract=null), Reference(id=1329914726563295711, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=阚淑月,于庆坤,王慧丽,等.药品说明书中儿童用药信息标注情况与儿童用药风险[J].中国医院药学杂志,2016,36(20):1801-1804., articleTitle=null, refAbstract=null), Reference(id=1329914726630404576, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=SALUNKE S, BRANDYS B, GIACOIA G, et al.The STEP(Safety and Toxicity of Excipients for Paediatrics) database: part 2 - the pilot version [J].Int J Pharm, 2013, 457(1): 310-322., articleTitle=null, refAbstract=null), Reference(id=1329914726697513441, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=海莉丽,朱琳,李智平.药物制剂辅料在儿童群体中的安全性考量[J].中国药学杂志,2019,54(14):1121-1125., articleTitle=null, refAbstract=null), Reference(id=1329914726764622306, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Inactive ingredients in approved drug products search: frequently asked questions [EB/OL].(2022-01-26)[2023-10-15].https://www.fda.gov/drugs/drug-approvals-and-databases/inactive-ingredients-approved-drug-products-search-frequently-asked-questions., articleTitle=null, refAbstract=null), Reference(id=1329914726827536867, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=GALANDE A D, KHURANA N A, MUTALIK S.Pediatric dosage forms - challenges and recent developments: a critical review [J].J Appl Pharm Sci, 2020, 10(7): 155-166., articleTitle=null, refAbstract=null), Reference(id=1329914726882062820, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=BUCKLEY L A, SALUNKE S, THOMPSON K, et al.Challenges and strategies to facilitate formulation development of pediatric drug products: safety qualification of excipients[J].Int J Pharm, 2018, 536(2): 563-569., articleTitle=null, refAbstract=null), Reference(id=1329914726944977381, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=TURNER M A, STORME T.European study for neonatal excipient exposure (ESNEE) [J].Eur J Hosp Pharm, 2012, 19(2): 67., articleTitle=null, refAbstract=null), Reference(id=1329914727012086246, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=VALEUR K S, HERTEL S A, LUNDSTRØM K E, et al.Safe excipient exposure in neonates and small children - protocol for the SEEN project [J].Dan Med J, 2017, 64(2): A5324., articleTitle=null, refAbstract=null), Reference(id=1329914727079195111, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=KOZAREWICZ P, LOFTSSON T.Novel excipients - regulatory challenges and perspectives - the EU insight [J].Int J Pharm, 2018, 546(1/2): 176-179., articleTitle=null, refAbstract=null), Reference(id=1329914727137915368, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Pilot program for the review of innovation and modernization of excipients (PRIME)[EB/OL].(2022-07-09)[2023-10-17].https://www.fda.gov/drugs/development-approval-process-drugs/pilot-program-review-innovation-and-modernization-excipients-prime., articleTitle=null, refAbstract=null), Reference(id=1329914727205024233, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=李永圆,陈晨,王海霞,等.儿童药物制剂存在的问题及其创新开发策略[J].中国现代应用药学,2022,39(12):1597-1603., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329914723283349928, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, xref=1., ext=[AuthorCompanyExt(id=1329914723295932841, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, companyId=1329914723283349928, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1329914723304321450, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, companyId=1329914723283349928, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1329914723388207531, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, xref=2., ext=[AuthorCompanyExt(id=1329914723396596140, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, companyId=1329914723388207531, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.China National Pharmaceutical Industry Information Center, Shanghai 200040), AuthorCompanyExt(id=1329914723409179053, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, companyId=1329914723388207531, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国医药工业信息中心,上海 200040)]), AuthorCompany(id=1329914723497259438, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, xref=3., ext=[AuthorCompanyExt(id=1329914723505648047, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, companyId=1329914723497259438, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203), AuthorCompanyExt(id=1329914723514036656, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, companyId=1329914723497259438, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.上海药品审评核查中心,上海 201203)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.07.017, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2024.07.017, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2024.07.017, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2024.07.017, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1720540800000, fullTextJson=null, articleText=null, reference=null)
收藏切换
儿童制剂用辅料的监管政策、挑战与发展趋势
王奇巍 1, 2 , 陈桂良 3, *
中国医药工业杂志 | 药学管理与信息 2024,55(7): 1024-1031
收起
收藏切换
中国医药工业杂志 |药学管理与信息 2024 , 55 (7) : 1024 -1031
儿童制剂用辅料的监管政策、挑战与发展趋势
全屏
[Author(id=1329914723581145522, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914723665031605, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, authorId=1329914723581145522, language=EN, stringName=Qiwei WANG, firstName=Qiwei, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.China State Institute of Pharmaceutical Industry, Shanghai 201203
2.China National Pharmaceutical Industry Information Center, Shanghai 200040, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914723736334774, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, authorId=1329914723581145522, language=CN, stringName=王奇巍, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.中国医药工业研究总院,上海 201203
2.中国医药工业信息中心,上海 200040, bio={"content":"

王奇巍(1984—),博士研究生,副研究员,专业方向:医药政策、医药信息研究。

"}, bioImg=null, bioContent=

王奇巍(1984—),博士研究生,副研究员,专业方向:医药政策、医药信息研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914723283349928, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, xref=1., ext=[AuthorCompanyExt(id=1329914723295932841, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, companyId=1329914723283349928, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1329914723304321450, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, companyId=1329914723283349928, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1329914723388207531, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, xref=2., ext=[AuthorCompanyExt(id=1329914723396596140, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, companyId=1329914723388207531, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.China National Pharmaceutical Industry Information Center, Shanghai 200040), AuthorCompanyExt(id=1329914723409179053, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, companyId=1329914723388207531, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国医药工业信息中心,上海 200040)])]), Author(id=1329914723811832248, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=chenguiliang@smda.sh.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329914723891524026, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, authorId=1329914723811832248, language=EN, stringName=Guiliang CHEN, firstName=Guiliang, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914723979604411, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, authorId=1329914723811832248, language=CN, stringName=陈桂良, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, *, address=3.上海药品审评核查中心,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914723497259438, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, xref=3., ext=[AuthorCompanyExt(id=1329914723505648047, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, companyId=1329914723497259438, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203), AuthorCompanyExt(id=1329914723514036656, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914722293494181, companyId=1329914723497259438, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.上海药品审评核查中心,上海 201203)])])]
王奇巍1, 2, 陈桂良3, *
作者信息
  • 1.中国医药工业研究总院,上海 201203
  • 2.中国医药工业信息中心,上海 200040
  • 3.上海药品审评核查中心,上海 201203
通讯作者:
陈桂良(1964—),男,研究员,博士生导师,从事药品监管科学的研究。E-mail:
作者简介:

王奇巍(1984—),博士研究生,副研究员,专业方向:医药政策、医药信息研究。

Regulatory Policies, Challenges and Development Trends of Excipients in Pediatric Formulations
Qiwei WANG1, 2, Guiliang CHEN3, *
Affiliations
  • 1.China State Institute of Pharmaceutical Industry, Shanghai 201203
  • 2.China National Pharmaceutical Industry Information Center, Shanghai 200040
  • 3.Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203
出版时间: 2024-07-10 doi: 10.16522/j.cnki.cjph.2024.07.017
文章导航
收藏切换

儿童是药物治疗的特殊群体,儿童与成人的生理特性和药物代谢特点存在差异。随着对儿童用药可及性的重视程度不断加深,越来越多的儿童适宜制剂亟待开发;而儿童对制剂用辅料的安全性和适宜性有着特殊要求。文章综述了全球主要国家和地区关于儿童制剂用辅料的监管政策和使用现状。尽管各国对儿童制剂用辅料出台了一些监管政策,但仍存在儿童频繁暴露于不安全辅料、药品说明书中辅料信息缺乏、儿童制剂可用辅料信息少等问题。对此,文章提出完善安全性评估体系、建立信息共享机制和加大创新辅料和创新技术研发的思路,以期促进儿童制剂用辅料的发展,为增进儿童的健康和福祉作出贡献。

儿童制剂用辅料  /  监管政策  /  发展趋势
王奇巍, 陈桂良. 儿童制剂用辅料的监管政策、挑战与发展趋势. 中国医药工业杂志, 2024 , 55 (7) : 1024 -1031 . DOI: 10.16522/j.cnki.cjph.2024.07.017
Qiwei WANG, Guiliang CHEN. Regulatory Policies, Challenges and Development Trends of Excipients in Pediatric Formulations[J]. Chinese Journal of Pharmaceuticals, 2024 , 55 (7) : 1024 -1031 . DOI: 10.16522/j.cnki.cjph.2024.07.017

参考文献 引证文献
排序方式:
[1]
BATCHELOR H K, MARRIOTT J F.Paediatric pharmacokinetics: key considerations [J].Br J Clin Pharmacol, 2015, 79(3): 395-404.
[2]
THABET Y, KLINGMANN V, BREITKREUTZ J.Drug formulations: standards and novel strategies for drug administration in pediatrics [J].J Clin Pharmacol, 2018, 58(Suppl 10): S26-S35.
[3]
TAN D C T, KHONG Y M, MOUNT S, et al.Pediatric formulation development - challenges of today and strategies for tomorrow: summary report from M-CERSI workshop 2019[J].Eur J Pharm Biopharm, 2021, 164: 54-65.
[4]
QUIJANO RUIZ B, DESFONTAINE E, ARENAS-LÓPEZ S, et al.Pediatric formulation issues identified in Paediatric Investigation Plans [J].Expert Rev Clin Pharmacol, 2014, 7(1): 25-30.
[5]
FABIANO V, MAMELI C, ZUCCOTTI G V.Paediatric pharmacology: remember the excipients [J].Pharmacol Res, 2011, 63(5): 362-365.
[6]
ROUAZ K, CHICLANA-RODRÍGUEZ B, NARDI-RICART A, et al.Excipients in the paediatric population: a review [J].Pharmaceutics, 2021, 13(3): 387.
[7]
Committee for Medicinal Products for Human Use.Reflection paper: formulations of choice for the paediatric population [EB/OL].(2007-07-28) [2023-10-08].https://www.ema.europa.eu/en/documents/scientific-guideline/reflection-paper-formulations-choice-paediatric-population_en.pdf.
[8]
EMA.Excipients in the dossier for application marketing authorisation of a medicinal product - scientific guideline [EB/OL].(2018-09-17)[2023-10-08].https://www.ema.europa.eu/en/excipients-dossier-application-marketing-authorisation-medicinal-product-scientific-guideline.
[9]
EMA.Pharmaceutical development of medicines for paediatric use [EB/OL].(2018-09-17)[2023-10-08].https://www.ema.europa.eu/en/pharmaceutical-development-medicines-paediatric-use-scientific-guideline.
[11]
FDA.Guidance for industry nonclinical studies for the safety evaluation of pharmaceutical excipients [EB/OL].[2023-10-08].https://www.fda.gov/media/72260/download.
[12]
SAITO J, AGRAWAL A, PATRAVALE V, et al.The current states, challenges, ongoing efforts, and future perspectives of pharmaceutical excipients in pediatric patients in each country and region [J].Children (Basel), 2022, 9(4): 453.
[13]
国家药品监督管理局药品审评中心.国家药监局药审中心关于发布《儿童用药(化学药品)药学开发指导原则(试行)》的通告(2020年第67号)[EB/OL].(2020-12-31)[2023-10-13].https://www.cde.org.cn/main/news/viewInfoCommon/95102a5facaf8fd4430d0916a24eab53.
[14]
原国家食品药品监督管理局.药品说明书和标签管理规定[EB/OL].(2006-03-15)[2023-10-13].https://www.samr.gov.cn/zw/zfxxgk/fdzdgknr/bgt/art/2023/art_b1a64fa-4b9314ecabadf3c6662b70c48.html.
[15]
国家药品监督管理局药品审评中心.国家药监局药审中心关于发布《化学药品说明书及标签药学相关信息撰写指导原则(试行)》的通告(2023年第20号)[EB/OL].(2023-03-20)[2023-10-13].https://www.cde.org.cn/main/news/viewInfoCommon/defca6a1f3ba33d0bad6f309e-5a0b816.
[16]
EMA.ICH Topic E11: clinical investigation of medicinal products in the paediatric population [EB/OL].[2023-10-08].https://www.ema.europa.eu/en/documents/scientific-guideline/e-11-clinical-investigation-medicinal-products-paediatric-population-step-5_en.pdf.
[17]
ICH.Addendum to ICH E11: clinical investigation of medicinal products in the pediatric population E11(R1) [EB/OL].(2017-08-18)[2023-10-08].https://database.ich.org/sites/default/files/E11_R1_Addendum.pdf.
[18]
WHO.TRS 885 - annex 5: WHO good manufacturing practices for the manufacture of pharmaceutical excipients[EB/OL].(1999-09-30)[2023-11-30].https://www.who.int/publications/m/item/trs885-annex5.
[19]
NELLIS G, METSVAHT T, VARENDI H, et al.Potentially harmful excipients in neonatal medicines: a pan-European observational study [J].Arch Dis Child, 2015, 100(7): 694-699.
[20]
LASS J, NAELAPÄÄ K, SHAH U, et al.Hospitalised neonates in Estonia commonly receive potentially harmful excipients [J].BMC Pediatr, 2012, 12: 136.
[21]
AKINMBONI T O, DAVIS N L, FALCK A J, et al.Excipient exposure in very low birth weight preterm neonates [J].J Perinatol, 2018, 38(2): 169-174.
[22]
许锦,刘彬,王庆阳,等.某三级甲等儿童医院中成药说明书辅料标明情况及风险控制建议[J].中国药师,2018,21(11):2020-2022.
[23]
TURNER M A, DUNCAN J C, SHAH U, et al.Risk assessment of neonatal excipient exposure: lessons from food safety and other areas [J].Adv Drug Deliv Rev, 2014, 73: 89-101.
[24]
BATCHELOR H K, FOTAKI N, KLEIN S.Paediatric oral biopharmaceutics: key considerations and current challenges[J].Adv Drug Deliv Rev, 2014, 73: 102-126.
[25]
STOLTENBERG I, WINZENBURG G, BREITKREUTZ J.Solid oral dosage forms for children - formulations, excipients and acceptance issues [J].J Appl Ther Res, 2010, 7(4): 141-146.
[26]
BREITKREUTZ J, BOOS J.Paediatric and geriatric drug delivery [J].Expert Opin Drug Deliv, 2007, 4(1): 37-45.
[27]
YOCHANA S, YU M, ALVI M, et al.Pharmaceutical excipients and pediatric formulations [J].Chim Oggi, 2012, 30(5): 56-61.
[28]
SHESKEY P J, COOK W G, CABLE C G.Handbook of pharmaceutical excipients [M].8th, London: Pharmaceutical Press, 2017.
[29]
NAKAMA K A, DOS SANTOS R B, SERPA P, et al.Organoleptic excipients used in pediatric antibiotics [J].Arch Pediatr, 2019, 26(7): 431-436.
[30]
MCCANN D, BARRETT A, COOPER A, et al.Food additives and hyperactive behaviour in 3-year-old and 8/9-year-old children in the community: a randomised, double-blinded, placebo-controlled trial [J].Lancet, 2007, 370(9598): 1560-1567.
[31]
SCHAB D W, TRINH N H.Do artificial food colors promote hyperactivity in children with hyperactive syndromes? A meta-analysis of double-blind placebo-controlled trials [J].J Dev Behav Pediatr, 2004, 25(6): 423-434.
[32]
高悦,江军飞.《国家基本医疗保险、工伤保险和生育保险目录(2020版)》儿童专用中成药现状调研[J].儿科药学杂志,2022,28(4):4-7.
[33]
阚淑月,于庆坤,王慧丽,等.药品说明书中儿童用药信息标注情况与儿童用药风险[J].中国医院药学杂志,2016,36(20):1801-1804.
[34]
SALUNKE S, BRANDYS B, GIACOIA G, et al.The STEP(Safety and Toxicity of Excipients for Paediatrics) database: part 2 - the pilot version [J].Int J Pharm, 2013, 457(1): 310-322.
[35]
海莉丽,朱琳,李智平.药物制剂辅料在儿童群体中的安全性考量[J].中国药学杂志,2019,54(14):1121-1125.
[36]
FDA.Inactive ingredients in approved drug products search: frequently asked questions [EB/OL].(2022-01-26)[2023-10-15].https://www.fda.gov/drugs/drug-approvals-and-databases/inactive-ingredients-approved-drug-products-search-frequently-asked-questions.
[37]
GALANDE A D, KHURANA N A, MUTALIK S.Pediatric dosage forms - challenges and recent developments: a critical review [J].J Appl Pharm Sci, 2020, 10(7): 155-166.
[38]
BUCKLEY L A, SALUNKE S, THOMPSON K, et al.Challenges and strategies to facilitate formulation development of pediatric drug products: safety qualification of excipients[J].Int J Pharm, 2018, 536(2): 563-569.
[39]
TURNER M A, STORME T.European study for neonatal excipient exposure (ESNEE) [J].Eur J Hosp Pharm, 2012, 19(2): 67.
[40]
VALEUR K S, HERTEL S A, LUNDSTRØM K E, et al.Safe excipient exposure in neonates and small children - protocol for the SEEN project [J].Dan Med J, 2017, 64(2): A5324.
[41]
KOZAREWICZ P, LOFTSSON T.Novel excipients - regulatory challenges and perspectives - the EU insight [J].Int J Pharm, 2018, 546(1/2): 176-179.
[42]
FDA.Pilot program for the review of innovation and modernization of excipients (PRIME)[EB/OL].(2022-07-09)[2023-10-17].https://www.fda.gov/drugs/development-approval-process-drugs/pilot-program-review-innovation-and-modernization-excipients-prime.
[43]
李永圆,陈晨,王海霞,等.儿童药物制剂存在的问题及其创新开发策略[J].中国现代应用药学,2022,39(12):1597-1603.
2024年第55卷第7期
28
7
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2024.07.017
  • 接收时间:2024-02-19
  • 首发时间:2026-11-18
  • 出版时间:2024-07-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2024-02-19
基金
作者信息
    1.中国医药工业研究总院,上海 201203
    2.中国医药工业信息中心,上海 200040
    3.上海药品审评核查中心,上海 201203

通讯作者:

陈桂良(1964—),男,研究员,博士生导师,从事药品监管科学的研究。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.07.017
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏